Bone health care in women with breast cancer

被引：7

作者：

Paschou, Stavroula A. ^{[1
]}

Augoulea, Areti ^{[1
]}

Lambrinoudaki, Irene ^{[1
]}

机构：

[1] Natl & Kapodistrian Univ Athens, Aretaieio Hosp, Med Sch, Dept Obstet & Gynaecol 2, Athens, Greece

来源：

HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM | 2020年 / 19卷 / 02期

关键词：

Breast cancer; Survivors; Aromatase inhibitors; Tamoxifen; Bone; BMD; Bisphosphonates; Denosumab; MHT; ADJUVANT ENDOCRINE THERAPY; 5-YEAR FOLLOW-UP; POSTMENOPAUSAL WOMEN; ZOLEDRONIC ACID; AROMATASE INHIBITOR; MINERAL DENSITY; PREMENOPAUSAL WOMEN; DOUBLE-BLIND; CLINICAL-PRACTICE; POSITION STATEMENT;

D O I：

10.1007/s42000-019-00164-y

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The aim of this article is to analyze and critically appraise the literature regarding optimal bone health care in women with breast cancer and, more specifically, to present (1) the causes of bone loss in breast cancer patients, (2) the appropriate screening for osteoporosis and fracture risk estimation, (3) optimal prevention and therapeutic strategies for osteoporosis and fractures, (4) the role of antiresorptive agents as adjuvant therapy for the prevention of bone metastases and increase of overall survival, and (5) current data on the possible use of menopausal hormone therapy (MHT) in these patients. The objective is to provide a sound pathophysiological background along with evidence-based and practical recommendations for physicians managing such women.

引用

页码：171 / 178

页数：8

共 50 条

[1] Correction to: Bone health care in women with breast cancer
Stavroula Α. Paschou
Areti Augoulea
Irene Lambrinoudaki
Hormones, 2020, 19 (2) : 265 - 265
[2] Bone health in women with breast cancer
Ramchand, S. K.
Cheung, Y. M.
Grossmann, M.
CLIMACTERIC, 2019, 22 (06) : 589 - 595
[3] Bone health in young women with breast cancer
Wendell, K. B.
Nadeem, S.
Martin, B.
Camacho, P. M.
Albain, K. S.
Robinson, P.
Lo, S. S.
CANCER RESEARCH, 2019, 79 (04)
[4] Bone health in women with breast cancer.
Ott, S. M.
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2006, 163 (11) : S82 - S82
[5] Aromatase inhibitors and bone health in women with breast cancer
Chien, Amy Jo
Goss, Paul E.
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (33) : 5305 - 5312
[6] AVOIDING THE BREAST CANCER AND BONE HEALTH CARE GAP
Carr, W. M.
OSTEOPOROSIS INTERNATIONAL, 2014, 25 : S702 - S703
[7] Barriers in health care to breast cancer: perception of women
Conceciao Goncalves, Leila Luiza
Travassos, Gabriela Lima
de Almeida, Ana Maria
D'Avila Nery Guimaraes, Alzira Maria
Lisboa Gois, Cristiane Franca
REVISTA DA ESCOLA DE ENFERMAGEM DA USP, 2014, 48 (03) : 394 - 400
[8] Health and Wellbeing in Portuguese Health Care Providers in Women With Breast Cancer
Cunha, Maria Joao
Pereira, Joao Paulo
Gascon, Santiago
Pereira, Joao
Costa, Marisa
PSYCHO-ONCOLOGY, 2013, 22 : 242 - 242
[9] Appraisal, Coping, Resources and Health of Breast Cancer Women: Advancing Health Equity, Policy, and Practice in the Care of Women with Breast Cancer
Sternas, Kathleen
NURSING RESEARCH, 2024, 73 (03) : E152 - E152
[10] Report on retrospective analysis of health care costs of bone fractures in women with early stage breast cancer
Redaelli, A
Zhou, Z
Willke, R
Massimini, G
VALUE IN HEALTH, 2003, 6 (06) : 732 - 733

← 1 2 3 4 5 →